Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.4690
+0.0290 (6.59%)
Last updated: Apr 24, 2026, 2:18 PM CET
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €8.17 million as of April 24, 2026. Its market cap has decreased by -3.26% in one year.
Market Cap
8.17M
Enterprise Value
12.25M
Revenue
1.74M
Ranking
n/a
PE Ratio
1.30
Stock Price
€0.47
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 8.17M, an increase of 40.34%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 7.97M | 6.80% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 35.47M |
| genOway Société anonyme | 23.05M |
| GenSight Biologics | 19.25M |
| Advicenne | 19.18M |
| Aelis Farma | 16.72M |
| Poxel | 14.48M |
| NFL Biosciences | 13.31M |
| Plant Advanced Technologies | 7.80M |